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In Reply
Tara C. Jatlaoui, MD, MPH, Maura K. Whiteman, PhD, Gary Jeng, PhD, Naomi K. Tepper, 
MD, MPH, and Kathryn M. Curtis, PhD
Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia
We appreciate the important considerations raised by Blumenthal and Lerma regarding our 
recent publication.1 We agree that continuation is an important programmatic outcome. 
However, intrauterine device (IUD) reinsertion after expulsion may not be feasible for all 
women owing to cost, insurance coverage, or logistical barriers. Therefore, expulsion is an 
essential contributor to continuation, and these data may inform patient-centered counseling.
To provide information pertinent to U.S. practice, we included data on copper and 
levonorgestrel IUDs that were ever available in the United States, rather than those included 
in a recent review.2 We agree that certain factors (eg, insertion technique and health care 
provider experience) may influence expulsion risk; however, these factors were not 
consistently reported by studies and therefore not included in our analysis.
We based our timing categories of postpartum IUD placement on U.S. Medical Eligibility 
Criteria for Contraceptive Use recommendations.3 The majority of data are reported by these 
categories, and studies examining the early postpartum period (more than 10 minutes after 
placental delivery to less than 4 weeks postpartum) did not provide sufficient data to 
separate expulsion rates into additional time periods. Ideally, future studies will describe 
outcomes, including uptake, expulsions, and continuation, associated with placements in the 
delivery room, during the hospital stay, or at an early postpartum visit to better inform 
postpartum contraception care and programs. Nonetheless, postpartum IUD placement is 
safe at any time and can be provided based on the woman’s preference.
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